These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 463898)

  • 21. Relative efficacy and palatability of three activated charcoal mixtures.
    Navarro RP; Navarro KR; Krenzelok EP
    Vet Hum Toxicol; 1980 Feb; 22(1):6-9. PubMed ID: 7361450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on in vitro paraquat and diquat removal by activated carbon.
    Terada H; Miyoshi T; Imaki M; Nakamura T; Tanada S
    Tokushima J Exp Med; 1994 Jun; 41(1-2):31-40. PubMed ID: 7940530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and performance of cross-linked agar encapsulated activated charcoal (CAAC-III).
    Chen YM; Tang XJ; Xu CX; Li ZM
    J Microencapsul; 1991; 8(3):327-34. PubMed ID: 1941439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of particle size on the adsorption of theophylline onto activated charcoal, in vitro study.
    Nakamura T; Kawasaki N; Matsumoto K; Tanada S
    Chudoku Kenkyu; 2003 Jan; 16(1):57-62. PubMed ID: 12712543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adsorption of fluoxetine HCl by activated charcoal.
    Cooney DO; Thomason R
    J Pharm Sci; 1997 May; 86(5):642-4. PubMed ID: 9145393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.
    Rademaker CM; van Dijk A; de Vries MH; Kadir F; Glerum JH
    Pharm Weekbl Sci; 1989 Apr; 11(2):56-60. PubMed ID: 2726418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine adsorption by activated charcoal.
    Chinouth RW; Czajka PA; Peterson RG
    Vet Hum Toxicol; 1980 Dec; 22(6):392-4. PubMed ID: 7210465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does multiple-dose charcoal therapy enhance salicylate excretion?
    Kirshenbaum LA; Mathews SC; Sitar DS; Tenenbein M
    Arch Intern Med; 1990 Jun; 150(6):1281-3. PubMed ID: 2191636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of thermodynamic parameters for the activated charcoal-phenobarbitone adsorption system.
    Agarwal S; Pal TK
    Boll Chim Farm; 1999 Sep; 138(8):422-6. PubMed ID: 10622108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and optimization of the activated charcoal suspension composition based on a mixture design approach.
    Ronowicz J; Kupcewicz B; Pałkowski Ł; Krysiński J
    Acta Pharm; 2015 Mar; 65(1):83-90. PubMed ID: 25781707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro study of lithium carbonate adsorption by activated charcoal.
    Favin FD; Klein-Schwartz W; Oderda GM; Rose SR
    J Toxicol Clin Toxicol; 1988; 26(7):443-50. PubMed ID: 3148035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro adsorption of sodium pentobarbital by SuperChar, USP and Darco G-60 activated charcoals.
    Curd-Sneed CD; Parks KS; Bordelon JG; Stewart JJ
    J Toxicol Clin Toxicol; 1987; 25(1-2):1-11. PubMed ID: 3586080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of activated charcoal on the disposition of sulphadoxine.
    Akintonwa A; Obodozie O
    Arch Int Pharmacodyn Ther; 1991; 309():185-92. PubMed ID: 1888227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on sodium sulphate on the adsorption of chloroquine and mefloquine to activated charcoal.
    Orisakwe OE; Akintonwa A
    East Afr Med J; 1991 Jun; 68(6):420-4. PubMed ID: 1752220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of saline cathartics on the adsorption of sulphamethoxazole to activated charcoal.
    Akintonwa A; Orisakwe OE
    Arch Int Pharmacodyn Ther; 1990; 304():290-5. PubMed ID: 2241416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation of activated charcoal for per os administration to addicted subjects.
    Flament MP; M'bisi R; Leterme P; Gayot AT
    Drug Dev Ind Pharm; 2000 Jul; 26(7):731-6. PubMed ID: 10872091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro adsorption of tilidine HCl by activated charcoal.
    Cordonnier JA; Van den Heede MA; Heyndrickx AM
    J Toxicol Clin Toxicol; 1986-1987; 24(6):503-17. PubMed ID: 3573124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.